ORDENTLICH PETER (Chief Scientific Officer) sold 25K shares of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $646.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/17/2023ACC: 0001562180-23-001533
Officer· Chief Scientific Officer
Since Feb 2019
-25K
Net shares
Net seller
$646.1K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.57K
Price / share
$6.38
Trade value
$48.31K
% of position
New position
2/15/2023
0.00→7.57K
Common Stock
Direct
Shares
−7.57K
Price / share
$25.84
Trade value
$195.69K
% of position
New position
2/15/2023
7.57K→0.00
Common Stock
Direct
Shares
+17.43K
Price / share
$7.20
Trade value
$125.48K
% of position
New position
2/15/2023
0.00→17.43K
Common Stock
Direct
Shares
−17.43K
Price / share
$25.84
Trade value
$450.40K
% of position
New position
2/15/2023
17.43K→0.00
Total
Net shares
+0.00
Net value
-$472.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | M · Option Exercise | +7.57K | $6.38 | $48.31K | New position | 0.00 | 7.57K |
| Common Stock Direct | 2/15/2023 | S · Sale | −7.57K | $25.84 | $195.69K | New position | 7.57K | 0.00 |
| Common Stock Direct | 2/15/2023 | M · Option Exercise | +17.43K | $7.20 | $125.48K | New position | 0.00 | 17.43K |
| Common Stock Direct | 2/15/2023 | S · Sale | −17.43K | $25.84 | $450.40K | New position | 17.43K | 0.00 |
| Total | +0.00 | -$472.30K | ||||||
Derivative Transactions2
Stock Options (Right to buy)
Direct
Converts to
Common Stock
17.43K shares
Shares
−17.43K
Strike price
7.20
Held after
0.00
Exercisable
—
2/15/2023
Stock Options (Right to buy)
Direct
Converts to
Common Stock
7.57K shares
Shares
−7.57K
Strike price
6.38
Held after
0.00
Exercisable
—
2/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock17.43K shares | 2/15/2023 | M · Option Exercise | −17.43K | 7.20 | — | 0.00 |
| Stock Options (Right to buy) Direct | Common Stock7.57K shares | 2/15/2023 | M · Option Exercise | −7.57K | 6.38 | — | 0.00 |